Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Open in API
Filings indexed 288 across all filing types
Latest filing 2019-12-16 AGM Information
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(제 21기 정기주주총회 권리주주확정을 위한 증권예탁증권 기준일 설정 공고)
AGM Information Classification · 95% confidence The document is a formal announcement regarding the setting of a record date for the 21st Annual General Meeting (AGM) to determine shareholder voting rights. It is a regulatory disclosure (자율공시) regarding meeting logistics rather than the meeting materials themselves or a financial report. Given it is a regulatory announcement regarding corporate governance and meeting procedures, it fits best under the RNS (Regulatory Filings) category.
2019-12-16 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Kolon TissueGene, covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial statements, business descriptions, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-29 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory filing regarding a lawsuit ('소송등의제기ㆍ신청') filed against Kolon TissueGene. It details the nature of the claim (damages), the amount, the court involved, and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant litigation.
2019-11-21 Korean
기타시장안내(코스닥시장위원회 심의결과 및 개선기간 부여 안내)
Regulatory Filings Classification · 95% confidence The document is a short announcement from the Korea Exchange regarding the KOSDAQ Market Committee's decision to grant an improvement period to Kolon TissueGene regarding its potential delisting. It is an official regulatory notice concerning the status of the company's listing, which fits the definition of a regulatory filing/announcement rather than a specific financial report or corporate action.
2019-10-11 Korean
주권매매거래정지기간변경(개선기간 부여)
Delisting Announcement Classification · 95% confidence The document is a short regulatory notice regarding the suspension of stock trading for Kolon TissueGene. It specifies the change in the suspension period due to an improvement period granted by the KOSDAQ market regulations. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2019-10-11 Korean
기타시장안내(코스닥시장위원회 개최기한 연장 안내)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the Korea Exchange regarding the extension of a deadline for the KOSDAQ Market Committee to deliberate on the delisting of Kolon TissueGene. It is a regulatory announcement concerning market status and listing procedures, not a formal delisting notice itself, nor does it fit into other specific categories like M&A or financial reports. Therefore, it falls under the general regulatory filing category.
2019-09-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.